Association between genotype and clinical course of amyotrophic lateral sclerosis

Association between genotype and clinical course of amyotrophic lateral sclerosis - Association between genotype and clinical course of amyotrophic lateral sclerosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030729

Enrollment

Registered

2018-01-25

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyotrophic lateral sclerosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as ALS, genetic analysis is performed with the review of the ethical committee on the human genome and genetic analysis research and approval of the hospital director, and patients with mutations in known genes

Exclusion criteria

Exclusion criteria: Cases for which patients or the legal representatives did not agree are excluded. Patients who did not have gene mutation as a result of genetic analysis examination are excluded.

Design outcomes

Primary

Measure	Time frame
Evaluate the relationship between gene mutation and information on medical record. Information on the medical record includes information on age, sex, height, weight, past history, age of onset, onset form, diagnosis findings and aging, ALSFRS-R (ALS function evaluation scale), riluzole and edaravone.	—

Countries

Japan

Contacts

Public ContactMami Kanzaki

Toranomon Hospital Kajigaya Department of Neurology

mami.kanzaki@gmail.com044-877-5111

Outcome results